2-Phenyl-thiazolidine-4-carboxylic acid

ID: ALA154191

Chembl Id: CHEMBL154191

Cas Number: 196930-46-8

PubChem CID: 11009168

Max Phase: Preclinical

Molecular Formula: C10H11NO2S

Molecular Weight: 209.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@@H]1CSC(c2ccccc2)N1

Standard InChI:  InChI=1S/C10H11NO2S/c12-10(13)8-6-14-9(11-8)7-4-2-1-3-5-7/h1-5,8-9,11H,6H2,(H,12,13)/t8-,9?/m0/s1

Standard InChI Key:  AZDYQBFYMBALBY-IENPIDJESA-N

Alternative Forms

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (2284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaIMP-1 Beta-lactamase (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla2 Beta-lactamase II (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACP5 Tartrate-resistant acid phosphatase type 5 (16 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 209.27Molecular Weight (Monoisotopic): 209.0510AlogP: 1.47#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 2.90CX Basic pKa: 6.63CX LogP: -0.41CX LogD: -1.14
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.77Np Likeness Score: -0.06

References

1. Nagasawa HT, Goon DJ, Muldoon WP, Zera RT..  (1984)  2-Substituted thiazolidine-4(R)-carboxylic acids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity.,  27  (5): [PMID:6716397] [10.1021/jm00371a006]
2. Song ZC, Ma GY, Lv PC, Li HQ, Xiao ZP, Zhu HL..  (2009)  Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.,  44  (10): [PMID:19423200] [10.1016/j.ejmech.2009.04.014]
3. Liu Y, Jing F, Xu Y, Xie Y, Shi F, Fang H, Li M, Xu W..  (2011)  Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.,  19  (7): [PMID:21382719] [10.1016/j.bmc.2011.02.019]
4. Chen P, Horton LB, Mikulski RL, Deng L, Sundriyal S, Palzkill T, Song Y..  (2012)  2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases.,  22  (19): [PMID:22921080] [10.1016/j.bmcl.2012.08.012]
5. Önen Bayram FE, Sipahi H, Acar ET, Kahveci Ulugöl R, Buran K, Akgün H..  (2016)  The cysteine releasing pattern of some antioxidant thiazolidine-4-carboxylic acids.,  114  [PMID:27017266] [10.1016/j.ejmech.2016.03.019]
6. Hussein WM, Feder D, Schenk G, Guddat LW, McGeary RP..  (2018)  Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics.,  157  [PMID:30107365] [10.1016/j.ejmech.2018.08.004]

Source